|
|
 |
|
Viewing report
|
|
|
|
U.S. Bio-Computing IT Market Bio-Computing & Pharmaceutical Companies, The Fusion of Computing and Drug Discovery: Technologies, Products, Vendors, Opportunities and Market Forecasts
Fuji-Keizai USA, Inc., Pages: 147
The combination of the bioscience industry with the IT infrastructure industry is emerging as an exciting emerging industry called bio-computing. This interesting industry made it possible for several genomics companies to sequence sections of the human genome. The bio-computing market is emerging at an important time when the bioscience companies need enormous computing power to make sense of the flood of data that is being generated in drug discovery R& D labs. This report seeks to review all the key elements of this interesting and important market. In some ways, this report is a call to action for IT vendors to join into to the emerging bio-computing market because opportunities are plentiful. This is unusual in a slowing economy. Unlike other industries, the bioscience companies take a long term view of their business, have cash to spend on IT infrastructure, need much help from IT consultants and are ready, willing and able to get started in building their IT infrastructures for their R& D operations. This report highlights the main items in the bioscience industry and what is driving the need for bio-computing IT infrastructure and why. This study reviews the key opportunities, the leading bio-computing IT vendors, and some of the key bioscience customers. This study uses case studies to provide a sense of what customers require. Profiles of bio-computing IT vendors highlight basic information about vendors that are offering key solutions in the emerging bio-computing market. This report projects a 5-year forecast and includes many table and figures to illustrate the data. Note: The research for this report was started in the late summer of 2001. At the time, the US economy was teetering on entering a recession. Nearly all the high tech business sectors had dropped in value and the stock market was headed lower. By most accounts, the US economy was expected to rebound by the beginning of 2002. As a result, we forecasted the bio-computing market to reach a certain level over a five-year timeframe. However, the tragic events of the September terrorist attacks on the World Trade Center in New York and the Pentagon in Washington caused us to lower our forecast by nearly one year.
Customers who bought this item also bought
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D: Technologies, Opportunities and Markets
World Bio-Informatics Market (2005-2010)
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Bio Nanotechnology
Mobile Broadband Computing: Device Market Forecasts & Business Model Scenarios
Bio/Pharma R&D Statistical Sourcebook 2008/2009
Bio Imaging
The US Bio-Chip Market for Pharmaceutical Drug Discovery: Technology, Strategic Alliance, Patent Dispute and Market Update, 2002
Grid Computing - Global Strategic Business Report
Can Cloud Computing Help Enterprises Weather the Economic Storm?
Bio-IT report
|
|
|
|
